You just read:

Global Blood Therapeutics Announces Publication of Preclinical GBT440 Results in British Journal of Haematology that Support Sickle Cell Disease (SCD) Program

News provided by

Global Blood Therapeutics, Inc.

Jul 08, 2016, 08:00 ET